Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03278340 · ClinicalTrials.gov registry record · NA
Using Technology to Scale-Up an Occupational Sun Protection Policy Program
A NA study, sponsored by Klein Buendel.
- Completed
- Registry status
- NA
- Development phase
- 2,644
- Enrollment target
NCT03278340: Completed NA study, sponsored by Klein Buendel.
NCT03278340 is a NA study that has completed, run by Klein Buendel. The registered enrollment target is 2,644 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03278340, a NA study, has completed, sponsored by Klein Buendel.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,644 participants
- Enrollment target
Study Summary
Comprehensive approaches that combine sun protection policy and education for outdoor workers can reduce their risk for skin cancer by reducing their exposure to solar ultraviolet radiation on the job. To effectively disseminate the investigators' evidence-based sun protection policy and education intervention, Sun Safe Workplaces, a balance of effectiveness and cost of scale-up methods is required. The investigators propose to translate the intervention using a technology-based delivery method and compare the cost effectiveness of the original intervention and the intervention delivered by technology in a study that models national distribution strategies to public safety and public works sectors.
Primary Outcome
Policies will be collected from work sites and coded at both before and after the intervention period. Project staff will code written workplace policy documents on the presence of 15 "content categories" in three domains: 1) environmental controls; 2) administrative procedures; and 3) personal protection practices. Presence of policy is defined as having one or more policy components present in the written workplace policy documents (value = 1) versus no content components present (value = 0).
Interventions
- BEHAVIORAL Sun Safe Workplaces - Technology
- BEHAVIORAL Sun Safe Workplaces -In Person
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,644 participants |
| Start Date | 2017-07-14 |
| Est. Completion | 2024-07-31 |
| Phase | NA |
What the finished NCT03278340 record still lists
NCT03278340 is an interventional study that assigns participants to a tested intervention. Its 2,644 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher).
The record links to 0 conditions, and to 2 interventions - of which Sun Safe Workplaces - Technology is the first listed.
NCT03278340 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03278340 about?
NCT03278340 is a clinical study titled "Using Technology to Scale-Up an Occupational Sun Protection Policy Program". Comprehensive approaches that combine sun protection policy and education for outdoor workers can reduce their risk for skin cancer by reducing their exposure to solar ultraviolet radiation on the job. To effectively disseminate the investigators' evidence-based sun protection policy and education i...
What is the current status of trial NCT03278340?
This trial is currently completed. It is a NA study. The enrollment target is 2,644 participants. The study started on 2017-07-14. Estimated completion is 2024-07-31.
What interventions are being tested in trial NCT03278340?
The interventions under investigation include: Sun Safe Workplaces - Technology (BEHAVIORAL), Sun Safe Workplaces -In Person (BEHAVIORAL).
Who is sponsoring clinical trial NCT03278340?
This trial is sponsored by Klein Buendel, which has 34 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03278340's enrollment target sits among peer trials
2,644 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI